Actively Recruiting
EEG Monitoring for Refractory Status Epilepticus
Led by Barts & The London NHS Trust · Updated on 2026-05-08
40
Participants Needed
1
Research Sites
384 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective randomized study to investigate the yield of continuous electroencephalogram (cEEG), as a diagnostic tool in intensive care unit (ICU), for patients with refractory status epilepticus (RSE) and the contribution of this test to the patient final outcome, compared with standard medical care. Specifically, the hypothesis is that the use of cEEG for patients with RSE will significantly reduce the length of in-hospital stay, mortality, and subsequent complications (such as infections or pressure ulcers). It is also predicted that quality of life will be higher following cEEG at 0, 3, 6 and 12 months after discharge. As there are currently no data available from previous studies assessing the impact of cEEG on markers of the final clinical outcome in patients with RSE, this study is going to start as a feasibility study, aiming to obtain initial data for the primary outcome measure, in order to perform a sample size calculation for a larger future trial. The pilot study will also assess the integrity of the study protocol, specifically the recruitment process and the consent procedure, and also determine the necessary costs for running a cEEG service in ICU for patients with RSE
CONDITIONS
Official Title
EEG Monitoring for Refractory Status Epilepticus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged > 16 years
- Consent obtained according to Mental Capacity Act 2005
- Patients admitted to ICU for treatment of status epilepticus or admitted for another reason and diagnosed with status epilepticus during their admission
- Convulsive status epilepticus defined by either tonic-clonic seizures lasting longer than 5 minutes, focal seizures with impaired consciousness lasting longer than 10 minutes, or non-convulsive status epilepticus as per Salzburg consensus criteria
- Status epilepticus that continues despite treatment with benzodiazepine and one antiepileptic medication
You will not qualify if you...
- Anoxic brain injury
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Royal London Hospital
London, United Kingdom, E1 1FR
Actively Recruiting
Research Team
V
Vasiliki Tsirka, Consutlant
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here